本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Regulus Therapeutics Inc

7.92
-0.0300-0.38%
盤後7.85-0.0690-0.87%19:29 EDT
成交量:71.23萬
成交額:564.52萬
市值:5.48億
市盈率:-10.95
高:7.98
開:7.91
低:7.88
收:7.95
資料載入中...
2022/07/15

重要事件披露

8-K - Current report
2022/06/27

重要事件披露

8-K - Current report
2022/06/13

重要事件披露

8-K - Current report
2022/05/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/12

重要事件披露

8-K - Current report
2022/03/11

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/10

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/02

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/12

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/01/05

重要事件披露

8-K - Current report
2022/01/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/09

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/12/08

SEC問詢函

CORRESP [Cover] - Correspondence
2021/12/02

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/11/30

重要事件披露

8-K - Current report